Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma.
about
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancerSDP1 is a peroxisome-proliferator-activated receptor gamma 2 co-activator that binds through its SCAN domainAdvances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and diseaseModulation of the transcriptional activity of peroxisome proliferator-activated receptor gamma by protein-protein interactions and post-translational modificationsIdentification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gammaThe non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell linesLipid microdomain modification sustains neuronal viability in models of Alzheimer's diseaseSemicarbazide-sensitive amine oxidase activation promotes adipose conversion of 3T3-L1 cellsAmine oxidase substrates mimic several of the insulin effects on adipocyte differentiation in 3T3 F442A cellsModulation of receptor phosphorylation contributes to activation of peroxisome proliferator activated receptor alpha by dehydroepiandrosterone and other peroxisome proliferatorsp300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectivelyCharacterization of the amino-terminal activation domain of peroxisome proliferator-activated receptor alpha. Importance of alpha-helical structure in the transactivating function.Peroxisome proliferator-activated receptor delta (PPARdelta )-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling.Interferon-gamma-induced regulation of peroxisome proliferator-activated receptor gamma and STATs in adipocytes.A concerted kinase interplay identifies PPARgamma as a molecular target of ghrelin signaling in macrophages.Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene.Conjugated linoleic acid induces human adipocyte delipidation: autocrine/paracrine regulation of MEK/ERK signaling by adipocytokinesAcetylation-defective mutant of Pparγ is associated with decreased lipid synthesis in breast cancer cellsTranscription of liver X receptor is down-regulated by 15-deoxy-Δ(12,14)-prostaglandin J(2) through oxidative stress in human neutrophilsRevisiting PPARγ as a target for the treatment of metabolic disordersShikonin suppresses ERK 1/2 phosphorylation during the early stages of adipocyte differentiation in 3T3-L1 cells.PPAR and immune system--what do we know?PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammationTargeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticalsControlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγActivation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activatorsFunction of PPARgamma and its ligands in lung cancer.Upregulation of SIRT1 by 17β-estradiol depends on ubiquitin-proteasome degradation of PPAR-γ mediated by NEDD4-1.Peroxisome proliferator-activated receptor-gamma: novel therapeutic target linking adiposity, insulin resistance, and atherosclerosis.Rosiglitazone but not losartan prevents Nrf-2 dependent CD36 gene expression up-regulation in an in vivo atherosclerosis model.Insulin signalling in human adipose tissue.A Role for the PPARgamma in Cancer Therapy.Modulation of PPAR activity via phosphorylationEnterococcus faecalis from newborn babies regulate endogenous PPARgamma activity and IL-10 levels in colonic epithelial cells.PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?F-box only protein 9 is an E3 ubiquitin ligase of PPARγ.Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.Brd2 inhibits adipogenesis via the ERK1/2 signaling pathway in 3T3-L1 adipocytesSerum regulates adipogenesis of mesenchymal stem cells via MEK/ERK-dependent PPARgamma expression and phosphorylation.Herpesvirus-associated ubiquitin-specific protease (HAUSP) modulates peroxisome proliferator-activated receptor γ (PPARγ) stability through its deubiquitinating activity.
P2860
Q21328702-CC6BC096-BF15-4938-95FE-6102BCA0A061Q24535573-8CF341D2-C090-400D-9A1E-C5D4850E9FC1Q24803926-A5012456-DFA8-4017-BD85-9A199D719B82Q27015807-6423DD80-3025-4DFE-9CEE-8F35E9D1B1D0Q28144779-AE47C341-5DBA-4475-AC5B-A3619D2ABE42Q28238709-C70E1135-74CC-4C75-A1D1-976AD9578AB7Q28278644-906984AE-8926-4898-BDD2-CFA34327180DQ28346379-F76E33FA-046F-41E2-B4D3-0339C71BFFD0Q28366268-F7956382-FD7E-49D9-B7C4-1446FE459B74Q28564380-6297CE51-BA5E-43FC-883B-3C26B62A8C35Q28609750-80B77A76-1281-470F-8897-DE2ED47084B6Q30323774-B9072662-DA5B-4192-B891-1AD22F4509E8Q31537639-0D5C949A-8CA0-4C4E-828F-51208E79C6C7Q31655647-FE311515-DFA5-469B-8E95-C40A4545092EQ33514871-8451C120-CEBA-453E-8622-2415D64C6F2FQ33964333-F0B9C49C-E916-4BFF-97B7-0B82DB148C95Q34312856-DF037738-EE34-4B8E-9223-6E37766869E2Q34365660-F57F538D-DF9E-4036-A7D4-6BA42FFA3669Q34463399-EED0B271-D433-4E9F-B45B-B42AB0F32A32Q34798213-BCBFB136-66DC-4F05-830D-FAD988A23816Q34898716-93A06BCE-234F-474F-8D6E-04F2F75B7569Q34913467-0852A704-164D-44F7-A73E-438D05952CC1Q35053566-FE8A3E03-D7B6-4857-BFA3-E7100FBF0735Q35129349-1528F6B2-474D-4D57-B7E1-166D826E474CQ35969865-3068B438-32BF-461F-9595-AEADC696B699Q36089433-E8354D87-3937-435E-BEB6-01689A8C6600Q36414175-C4F6AFB8-5D88-4B17-BD84-31ECFC14C686Q36437294-EDCC234E-AEF0-47E9-A46F-0A11069FECE5Q36454248-F4A14332-97A4-4D1F-845E-16D71731B38EQ36494309-05B47249-2116-4FC1-A88B-4A4AA28D631FQ36576533-BF5BDFC4-C426-441F-90BC-251AEA0C2E90Q36691611-D63D1F41-B25A-4EE0-930C-4FED0FED680CQ36846134-F058EC67-5D98-4D29-91B8-88295A2B3F2BQ36882991-BF07780E-E652-4A99-9545-428A8CB57409Q36889164-2B3D1344-F02C-47BB-869E-7E4204A0D700Q37010704-63782EDA-CEDB-46D0-96F5-C92543FA7A81Q37045258-33E106F8-6DAB-4714-813E-58942D9B113DQ37251522-5386EA08-9127-4BFD-829B-AAA16FC53C7FQ37295287-46524AD2-9AE3-4D27-B039-048B2EF1325FQ37311332-2F572E1B-9E2C-45D5-9F09-B2DCDA2943C1
P2860
Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Insulin- and mitogen-activated ...... ator-activated receptor gamma.
@en
Insulin- and mitogen-activated ...... ator-activated receptor gamma.
@nl
type
label
Insulin- and mitogen-activated ...... ator-activated receptor gamma.
@en
Insulin- and mitogen-activated ...... ator-activated receptor gamma.
@nl
prefLabel
Insulin- and mitogen-activated ...... ator-activated receptor gamma.
@en
Insulin- and mitogen-activated ...... ator-activated receptor gamma.
@nl
P2093
P2860
P356
P1476
Insulin- and mitogen-activated ...... ator-activated receptor gamma.
@en
P2093
A Elbrecht
D E Moller
D Szalkowski
S White-Carrington
P2860
P304
31771-31774
P356
10.1074/JBC.271.50.31771
P407
P577
1996-12-01T00:00:00Z